ACRS · Aclaris Therapeutics, Inc.
$5.12
-0.21 (-3.94%)
At close · Jul 29
Market Cap
$744.41M
Shares
139.66M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2023-10-23 | JOSEPH B MONAHAN | Officer | 6,000 | 2023-10-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-21 | JOSEPH B MONAHAN | Officer | 6,000 | 2023-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-06-20 | JOSEPH B MONAHAN | Officer | 6,000 | 2023-06-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
18 filings
18 filers
Visit website
Investor relations